BioLineRx Ltd.
BLRX
$2.94
-$0.16-5.16%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.82M | 484.00K | -696.00K | -13.88M | -16.02M |
| Total Depreciation and Amortization | 840.00K | 476.00K | 897.00K | 647.00K | 221.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 59.00K | -- |
| Total Other Non-Cash Items | -1.41M | -5.09M | -3.54M | 3.46M | 4.73M |
| Change in Net Operating Assets | -3.43M | -7.20M | -10.77M | 14.71M | 1.17M |
| Cash from Operations | -9.83M | -11.33M | -14.11M | 4.99M | -9.90M |
| Capital Expenditure | 0.00 | -27.00K | -32.00K | -16.00K | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.18M | -8.62M | 16.72M | -20.38M | 4.10M |
| Cash from Investing | 10.18M | -8.65M | 16.69M | -20.40M | 4.10M |
| Total Debt Issued | 0.00 | 19.22M | -- | -- | -- |
| Total Debt Repaid | -1.04M | -909.00K | -894.00K | -863.00K | -942.00K |
| Issuance of Common Stock | -- | 5.57M | -- | 12.60M | 4.44M |
| Repurchase of Common Stock | -180.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.22M | 23.88M | -894.00K | 11.74M | 3.50M |
| Foreign Exchange rate Adjustments | 81.00K | -272.00K | 51.00K | 192.00K | -72.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -787.00K | 3.63M | 1.74M | -3.47M | -2.38M |
